Severe Atherosclerotic Changes, Including Aortic Occlusion, Associated with Hyperhomocysteinaemia and Antiphospholipid Antibodies
Overview
Authors
Affiliations
Three patients are described with severe systemic atherosclerosis, including aortic occlusion, in the presence of a spectrum of risk factors, including hypercholesterolaemia, hypertension, a positive family history of cardiovascular problems, and hyperhomocysteinaemia. In all three patients high levels of anticardiolipin antibodies were found. The possible pathogenic role of antiphospholipid antibodies in atherosclerosis in the context of hyperhomocysteinaemia in these patients is discussed.
Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.
Gaspar P, Sciascia S, Tektonidou M Rheumatology (Oxford). 2024; 63(SI):SI24-SI36.
PMID: 38320589 PMC: 10846913. DOI: 10.1093/rheumatology/kead571.
Dyslipidemia and its relationship with antiphospholipid antibodies in APS patients in North Kerala.
Sadanand S, Paul B, Thachil E, Meletath R Eur J Rheumatol. 2017; 3(4):161-164.
PMID: 28149659 PMC: 5283563. DOI: 10.5152/eurjrheum.2016.16041.
Systemic antiphospholipid syndrome and atherosclerosis.
Jara L, Medina G, Vera-Lastra O Clin Rev Allergy Immunol. 2007; 32(2):172-7.
PMID: 17916989 DOI: 10.1007/s12016-007-0008-9.
Medina G, Casaos D, Jara L, Vera-Lastra O, Fuentes M, Barile L Ann Rheum Dis. 2003; 62(7):607-10.
PMID: 12810420 PMC: 1754607. DOI: 10.1136/ard.62.7.607.
Atherosclerosis and antiphospholipid syndrome.
Jara L, Medina G, Vera-Lastra O, Shoenfeld Y Clin Rev Allergy Immunol. 2003; 25(1):79-88.
PMID: 12794263 DOI: 10.1385/CRIAI:25:1:79.